A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
Clinical trial NCT05127434 · COMPLETED
Trial details
- NCT number
- NCT05127434
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2025-07-28
- Enrollment
- 36814
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.